Avalon BioVentures SPV I, L.P.
CIK 0001844550 Name as filed on the most recent filing
Filed as Avalon BioVentures SPV I, L.P. (7)
49 transaction lines · from 7 filings · filed 2021-06-16 to 2024-10-18 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.
A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.
Issuers this insider has filed against
Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
No issuer is recorded
The catalog holds no filing linking this CIK to an issuer.
Transactions
Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.
0 transactions · Newest transaction date first, id breaking the tie.
This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.
| Direction | Date | Issuer | Code | Shares | Price | Value USD | Filing |
|---|---|---|---|---|---|---|---|
| 2024-10-18 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 553,219 disposed | 44.75 | 24,756,550.25 | Form 4, filing 0001415889-24-025436 | |
| 2024-10-18 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 541,824 disposed | 44.75 | 24,246,624.00 | Form 4, filing 0001415889-24-025436 | |
| 2024-10-18 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 104,957 disposed | 44.75 | 4,696,825.75 | Form 4, filing 0001415889-24-025436 | |
| 2024-10-18 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 104,892 disposed | 50.30 | 5,276,067.60 | Form 4, filing 0001415889-24-025436 | |
| 2024-10-18 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 102,732 disposed | 50.30 | 5,167,419.60 | Form 4, filing 0001415889-24-025436 | |
| 2024-10-18 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 19,900 disposed | 50.30 | 1,000,970.00 | Form 4, filing 0001415889-24-025436 | |
| 2024-10-18 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 15,788 disposed | 51.18 | 808,029.84 | Form 4, filing 0001415889-24-025436 | |
| 2024-10-18 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 15,462 disposed | 51.18 | 791,345.16 | Form 4, filing 0001415889-24-025436 | |
| 2024-10-18 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 2,995 disposed | 51.18 | 153,284.10 | Form 4, filing 0001415889-24-025436 | |
| 2024-10-17 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 1,843 disposed | 50.02 | 92,186.86 | Form 4, filing 0001415889-24-025436 | |
| 2024-10-16 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 61,445 disposed | 49.69 | 3,053,202.05 | Form 4, filing 0001415889-24-025436 | |
| 2024-10-16 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 60,179 disposed | 49.69 | 2,990,294.51 | Form 4, filing 0001415889-24-025436 | |
| 2024-10-16 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 30,094 disposed | 50.61 | 1,523,057.34 | Form 4, filing 0001415889-24-025436 | |
| 2024-10-16 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 29,474 disposed | 50.61 | 1,491,679.14 | Form 4, filing 0001415889-24-025436 | |
| 2024-10-16 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 11,657 disposed | 49.69 | 579,236.33 | Form 4, filing 0001415889-24-025436 | |
| 2024-10-16 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 10,957 disposed | 50.80 | 556,615.60 | Form 4, filing 0001415889-24-025436 | |
| 2024-10-16 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 5,710 disposed | 50.61 | 288,983.10 | Form 4, filing 0001415889-24-025436 | |
| 2024-09-30 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 958 disposed | 46.24 | 44,297.92 | Form 4, filing 0001415889-24-024119 | |
| 2024-09-27 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 46,861 disposed | 46.42 | 2,175,287.62 | Form 4, filing 0001415889-24-024119 | |
| 2024-09-27 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 45,894 disposed | 46.42 | 2,130,399.48 | Form 4, filing 0001415889-24-024119 | |
| 2024-09-27 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 8,894 disposed | 46.42 | 412,859.48 | Form 4, filing 0001415889-24-024119 | |
| 2024-09-27 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 1,826 disposed | 46.19 | 84,342.94 | Form 4, filing 0001415889-24-024119 | |
| 2024-09-27 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 1,542 disposed | 47.74 | 73,615.08 | Form 4, filing 0001415889-24-024119 | |
| 2024-09-27 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 1,511 disposed | 47.74 | 72,135.14 | Form 4, filing 0001415889-24-024119 | |
| 2024-09-27 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 293 disposed | 47.74 | 13,987.82 | Form 4, filing 0001415889-24-024119 | |
| 2024-09-26 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 50,539 disposed | 46.78 | 2,364,214.42 | Form 4, filing 0001415889-24-024119 | |
| 2024-09-26 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 49,497 disposed | 46.78 | 2,315,469.66 | Form 4, filing 0001415889-24-024119 | |
| 2024-09-26 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 41,661 disposed | 47.77 | 1,990,145.97 | Form 4, filing 0001415889-24-024119 | |
| 2024-09-26 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 40,803 disposed | 47.77 | 1,949,159.31 | Form 4, filing 0001415889-24-024119 | |
| 2024-09-26 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 9,592 disposed | 46.78 | 448,713.76 | Form 4, filing 0001415889-24-024119 | |
| 2024-09-26 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 7,908 disposed | 47.77 | 377,765.16 | Form 4, filing 0001415889-24-024119 | |
| 2024-09-12 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 161,356 disposed | 47.00 | 7,583,732.00 | Form 4, filing 0001415889-24-023337 | |
| 2024-09-12 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 158,031 disposed | 47.00 | 7,427,457.00 | Form 4, filing 0001415889-24-023337 | |
| 2024-09-12 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 30,613 disposed | 47.00 | 1,438,811.00 | Form 4, filing 0001415889-24-023337 | |
| 2024-09-10 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 35,047 disposed | 46.66 | 1,635,293.02 | Form 4, filing 0001415889-24-023337 | |
| 2024-09-10 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 34,326 disposed | 46.66 | 1,601,651.16 | Form 4, filing 0001415889-24-023337 | |
| 2024-09-10 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 11,557 disposed | 46.13 | 533,124.41 | Form 4, filing 0001415889-24-023337 | |
| 2024-09-10 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 11,319 disposed | 46.13 | 522,145.47 | Form 4, filing 0001415889-24-023337 | |
| 2024-09-10 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 6,649 disposed | 46.66 | 310,242.34 | Form 4, filing 0001415889-24-023337 | |
| 2024-09-10 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 2,193 disposed | 46.13 | 101,163.09 | Form 4, filing 0001415889-24-023337 | |
| 2024-09-09 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 2,182 disposed | 42.33 | 92,364.06 | Form 4, filing 0001415889-24-023153 | |
| 2024-09-06 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 110,644 disposed | 42.00 | 4,647,048.00 | Form 4, filing 0001415889-24-023153 | |
| 2024-09-06 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 108,365 disposed | 42.00 | 4,551,330.00 | Form 4, filing 0001415889-24-023153 | |
| 2024-09-06 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 20,991 disposed | 42.00 | 881,622.00 | Form 4, filing 0001415889-24-023153 | |
| 2024-06-03 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 691,525 disposed | 54.75 | 37,860,993.75 | Form 4, filing 0001415889-24-015673 | |
| 2024-06-03 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 677,279 disposed | 54.75 | 37,081,025.25 | Form 4, filing 0001415889-24-015673 | |
| 2024-06-03 |
Janux Therapeutics, Inc. JANX |
S, Open-market sale | 131,196 disposed | 54.75 | 7,182,981.00 | Form 4, filing 0001415889-24-015673 | |
| 2023-11-13 |
Janux Therapeutics, Inc. JANX |
P, Open-market purchase | 849,854 acquired | 5.87 | 4,988,642.98 | Form 4, filing 0001209191-23-055083 | |
| 2021-06-15 |
Janux Therapeutics, Inc. JANX |
P, Open-market purchase | 629,411 acquired | 17.00 | 10,699,987.00 | Form 4, filing 0001209191-21-041032 |
This column is intentionally blank
No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.
- S, Open-market sale
- Open-market sale
- P, Open-market purchase
- Open-market purchase
Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.
What this insider's stored lines contain
No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.
How to cite this page
ebomi catalog. Avalon BioVentures SPV I, L.P., insider transactions. Retrieved 2026-08-20 from https://ebomi.com/insider/0001844550
Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6